Amelia Filippelli
Salerno, 84100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications
RAS Inhibitors: Changing the Paradigm from the Undruggable.
Journal: Pharmaceutics
Published: April 30, 2026
Ticagrelor 60 mg vs. 90 mg in elderly ACS patients with vs. without diabetes undergoing percutaneous coronary intervention.
Journal: Journal of thrombosis and thrombolysis
Published: April 30, 2026
A prospective multimethod investigation of cancer-related pain integrating clinical data and machine learning: results from the RUGGI Study.
Journal: Journal of anesthesia, analgesia and critical care
Published: January 16, 2026
Do Cenobamate Pharmacokinetics Change with Co-Administered Antiseizure Medications? An Exploratory Analysis of Responder Patients with Focal Drug-Resistant Epilepsy.
Journal: Pharmaceutics
Published: December 24, 2025
Pharmacogenetic testing in Italy: results of a nationwide survey by the Joint Working Group for the pharmacogenetics implementation in Italy.
Journal: European journal of human genetics : EJHG
Published: December 20, 2025
Pre-emptive pharmacogenetic testing in Italy: a review of evidence and multidisciplinary consensus on key priorities for implementation.
Journal: Frontiers in public health
Published: December 09, 2025
Sex differences in levodopa pharmacokinetics in early Parkinson's disease: implications on levodopa-related complications.
Journal: Frontiers in pharmacology
Published: November 18, 2025
rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in patients with advanced cancer treated with anti-PD-1/PD-L1 therapy.
Journal: Journal for immunotherapy of cancer
Published: November 05, 2025
Effects of Natural Health Products in Combination with FP-Based Chemotherapy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 25, 2025
Sex differences among elderly ACS patients undergoing percutaneous coronary intervention receiving Ticagrelor 60 mg vs. 90 mg.
Journal: Journal of thrombosis and thrombolysis
Published: September 16, 2025
Efficacy and Safety of Anti-Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab in Neonates: A Real-World Monocentric Study.
Journal: Vaccines
Published: June 21, 2025
Last Updated: 09/26/2026